Skip to main content
Top
Published in: Pediatric Rheumatology 1/2020

Open Access 01-12-2020 | Commentary

Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019

Authors: Eve M. D. Smith, Sammy Ainsworth, Michael W. Beresford, Veerle Buys, Wendy Costello, Yona Egert, Helen E. Foster, Lovro Lamot, Berent J. Prakken, Christiaan Scott, Simon R. Stones

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

There is a lack of awareness of paediatric rheumatic diseases (PRDs), among the public, and certain groups of healthcare professionals (HCPs), including general practitioners. To help improve international awareness and understanding of PRDs, World yOung Rheumatic Diseases (WORD) Day was established on 18 March 2019. Its aim was to raise awareness of PRDs and the importance of timely referral plus early diagnosis and access to appropriate treatment and support. A steering committee was established, and an external agency provided digital support. A social media campaign was launched in December 2018 to promote it, and analytics were used to measure its impact. Face-to-face and virtual events took place globally on or around WORD Day 2019, with 34 countries reporting events. Examples included lectures, social gatherings and media appearances. A total of 2585 and 660 individuals followed the official Facebook and Twitter accounts respectively, up until WORD Day. The official #WORDDay2019 hashtag was seen by 533,955 unique accounts on 18 March 2019 alone, with 3.3 million impressions. WORD Day 2019 was the first international campaign focused solely on PRDs. It demonstrated that despite awareness events being often resource-light, they can be implemented across a range of diverse settings. WORD Day has now become an annual global awareness event, facilitated by a growing network of patient, parent and professional community supporters.
Literature
1.
go back to reference Giancane G, Alongi A, Rosina S, Tibaldi J, Consolaro A, Ravelli A. Recent therapeutic advances in juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2017;31(4):476–87.CrossRef Giancane G, Alongi A, Rosina S, Tibaldi J, Consolaro A, Ravelli A. Recent therapeutic advances in juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2017;31(4):476–87.CrossRef
2.
go back to reference Harris JG, Bingham CA, Morgan EM. Improving care delivery and outcomes in pediatric rheumatic diseases. Curr Opin Rheumatol. 2016;28(2):110–6.CrossRef Harris JG, Bingham CA, Morgan EM. Improving care delivery and outcomes in pediatric rheumatic diseases. Curr Opin Rheumatol. 2016;28(2):110–6.CrossRef
3.
go back to reference McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SEA, Davidson JE, et al. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with juvenile idiopathic arthritis: results from the childhood arthritis prospective study. Rheumatology. 2016;55(7):1225–34.CrossRef McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SEA, Davidson JE, et al. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with juvenile idiopathic arthritis: results from the childhood arthritis prospective study. Rheumatology. 2016;55(7):1225–34.CrossRef
4.
go back to reference Foster H, Rapley T, May C. Juvenile idiopathic arthritis: improved outcome requires improved access to care. Rheumatology. 2009;49(3):401–3.CrossRef Foster H, Rapley T, May C. Juvenile idiopathic arthritis: improved outcome requires improved access to care. Rheumatology. 2009;49(3):401–3.CrossRef
5.
go back to reference Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AEM, Foster HE. United Kingdom survey of current management of juvenile localized scleroderma. Rheumatology. 2014;53(10):1849–54.CrossRef Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AEM, Foster HE. United Kingdom survey of current management of juvenile localized scleroderma. Rheumatology. 2014;53(10):1849–54.CrossRef
6.
go back to reference Smith EMD, Foster HE, Gray WK, Taylor-Robinson D, Beresford MW. Group obotUJS. Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE cohort study. Rheumatology. 2013;53(3):557–61.CrossRef Smith EMD, Foster HE, Gray WK, Taylor-Robinson D, Beresford MW. Group obotUJS. Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE cohort study. Rheumatology. 2013;53(3):557–61.CrossRef
7.
go back to reference Egert Y, Egert T, Costello W, Prakken BJ, Smith EMD, Wulffraat NM. Children and young people get rheumatic disease too. Lancet Child Adolesc Health. 2019;3(1):8–9.CrossRef Egert Y, Egert T, Costello W, Prakken BJ, Smith EMD, Wulffraat NM. Children and young people get rheumatic disease too. Lancet Child Adolesc Health. 2019;3(1):8–9.CrossRef
8.
go back to reference WORD Day Steering Committee. WORD Day 2019 impact report. 2019. WORD Day Steering Committee. WORD Day 2019 impact report. 2019.
9.
go back to reference TrackMaven. 2017 Digital Marketing Analytics Performance Report 2017. TrackMaven. 2017 Digital Marketing Analytics Performance Report 2017.
Metadata
Title
Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019
Authors
Eve M. D. Smith
Sammy Ainsworth
Michael W. Beresford
Veerle Buys
Wendy Costello
Yona Egert
Helen E. Foster
Lovro Lamot
Berent J. Prakken
Christiaan Scott
Simon R. Stones
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00465-2

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue